Author: Petersen, Maria Skaalum; Kristiansen, Marnar FrÃðheim; Hanusson, Katrin Dahl; Danielsen, Marjun Eivindardóttir; á Steig, Bjarni; Gaini, Shahin; Strøm, Marin; Weihe, Pál
Title: Long COVID in the Faroe Islands - a longitudinal study among non-hospitalized patients Cord-id: fxwszm22 Document date: 2020_11_30
ID: fxwszm22
Snippet: BACKGROUND: Little is known about long-term recovery from COVID-19 disease, especially in non-hospitalized individuals. In this longitudinal study we present symptoms registered during the acute phase as well as long COVID, i.e. long-lasting COVID-19 symptoms, in patients from the Faroe Islands. METHODS: All consecutive patients with confirmed RT-PCR testing from April to June 2020 were invited to participate in this study for the assessment of long COVID. Demographic and clinical characteristic
Document: BACKGROUND: Little is known about long-term recovery from COVID-19 disease, especially in non-hospitalized individuals. In this longitudinal study we present symptoms registered during the acute phase as well as long COVID, i.e. long-lasting COVID-19 symptoms, in patients from the Faroe Islands. METHODS: All consecutive patients with confirmed RT-PCR testing from April to June 2020 were invited to participate in this study for the assessment of long COVID. Demographic and clinical characteristics and self-reported acute and persistent symptoms were assessed using a standardized detailed questionnaire administered at enrollment and at repeated phone interviews in the period 22 (th) April to Aug 16 (th). RESULTS: Of the 180 participants (96.3% of the 187 eligible COVID-19 patients), 53.1% reported persistence of at least one symptom after a mean of 125 days after symptoms onset, 33.3% reported one or two symptoms and 19.4% three or more symptoms. At the last follow-up, 46.7% were asymptomatic compared with 4.4 % during the acute phase. The most prevalent persistent symptoms were fatigue, loss of smell and taste, and arthralgias. CONCLUSIONS: Our results show that it might take months for symptoms to resolve, even among non-hospitalized persons with mild illness course in the acute phase. Continued monitoring for long COVID is needed.
Search related documents:
Co phrase search for related documents- absence presence and active recovery: 1
- absence presence and acute disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- absence presence and acute illness: 1, 2, 3, 4, 5, 6
- absence presence and acute phase: 1, 2, 3, 4, 5, 6, 7, 8
- absence presence and acute recovery: 1
- absence presence and long covid: 1, 2, 3, 4, 5, 6
- active disease and acute disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- active disease and acute illness: 1, 2, 3, 4, 5, 6
- active disease and acute phase: 1, 2, 3, 4, 5
- active disease and acute phase time: 1
- active disease and acute recovery: 1, 2
- active disease and long covid: 1, 2, 3, 4, 5, 6, 7
- active recovery and acute disease: 1, 2, 3
- active recovery and acute recovery: 1, 2, 3
- active recovery and long covid: 1
- acute disease and long covid: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute disease and long covid assessment: 1, 2, 3
- acute disease and long covid monitor: 1
- acute illness and long covid: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
Co phrase search for related documents, hyperlinks ordered by date